New MS Treatment Shows Promise in Trial

New MS Treatment Shows Promise in Trial
By

The drug ublituximab beat a standard oral medication for MS in reducing patients' relapses and proved better at preventing areas of inflammatory damage in the brain.

August 26, 2022 at 01:10AM
via WebMD Health read more...